Actively Recruiting
Open-label Phase 1b2 Study of 225Ac-DOTATATE RYZ101 in ER, HER2-negative Unresectable or Metastatic Breast Cancer Expressing Somatostatin Receptors
Led by RayzeBio, Inc. · Updated on 2026-10-06
64
Participants Needed
31
Research Sites
265 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating 225Ac-DOTATATE RYZ101 in a Phase 1b2 open-label trial involving people with estrogen receptor-positive ER, HER2-negative locally advanced, unresectable, or metastatic breast cancer that expresses somatostatin receptors SSTRs. The study focuses on patients with tumors not suitable for curative treatment and aims to understand the safety and dosing of RYZ101 alone and in combination with standard endocrine therapies. This trial is sponsored by RayzeBio, Inc. Participants receive escalating doses of RYZ101 intravenously either as a monotherapy or alongside an investigator-selected standard endocrine therapy such as anastrozole, elacestrant, exemestane, fulvestrant, imlunestrant, letrozole, tamoxifen, or vepdegestrant. There are two experimental arms one testing RYZ101 alone and another combining it with endocrine therapy. The treatment periods include dose escalation phases lasting about 6 weeks, followed by long-term monitoring up to approximately 5 years after the last RYZ101 treatment to assess ongoing effects. During the study, participants undergo imaging tests to confirm receptor presence and monitor disease, along with regular assessments of kidney, blood, and liver function. Researchers evaluate dose levels, disease progression, and safety over time, especially focusing on patients response to the combination therapies. This long-term follow-up helps track outcomes and any delayed effects of treatment, ensuring comprehensive monitoring throughout the study duration which may extend up to 5 years post-treatment.
CONDITIONS
Brief Title
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
Research Team
R
RayzeBio Clinical Trials
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here